SENSEX NIFTY

Astrazeneca

Nov 24, 2014 at 15:24 | Source: Moneycontrol.com
AstraZeneca Pharma India Ltd has informed BSE that Mr. Robert Haxton has resigned as the Wholetime Director of the Company. The Board has accepted the resignation of Mr. Haxton and that he would be relieved from the said position, effective December 14, 2014.
Nov 18, 2014 at 19:39 | Source: CNBC-TV18
USFDA had revoked tentative approvals granted to Ranbaxy for generic versions of two drugs - AstraZeneca's heartburn drug Nexium & Roche's antiviral drug Valcyte.
Nov 18, 2014 at 14:55 | Source: Reuters
In the suit filed in the District Court for the District of Columbia, Ranbaxy said the FDA's move violated constitutional rights, exceeded the agency's statutory authority, and was "arbitrary, capricious, and otherwise contrary to law."
Nov 07, 2014 at 10:14 | Source: CNBC-TV18
Ranbaxy has first-to-file status, meaning eligibility for six months of generic sales exclusivity for both AstraZeneca's heartburn drug Nexium & Roche's antiviral drug Valcyte drugs. However, the final approvals for these drugs were delayed because of the compliance issues at Ranbaxy's plants.
Nov 05, 2014 at 10:16 | Source: Moneycontrol.com
Glenmark Generics Inc., USA the subsidiary of Glenmark Generics has been granted final approval for its abbreviated new drug application from the USFDA for Omeprazole Delayed Release Capsules, their generic version of Prilosec by AstraZeneca.
Nov 04, 2014 at 18:02 | Source: Moneycontrol.com
AstraZeneca Pharma has reported a standalone total income from operations of Rs 114.67 crore and a net loss of Rs 27.96 crore for the quarter ended Sep '14
Nov 04, 2014 at 10:47 | Source: PTI
AstraZeneca's total income from operation during the quarter under review was at Rs 114.67 crore against Rs 115.66 crore in the second quarter of the last fiscal.
Nov 03, 2014 at 21:52 | Source: Moneycontrol.com
AstraZeneca Pharma India at its meeting held on November 03, 2014, has appointed Ms. Rebekah Martin as an Additional Director of the Company, effective November 03, 2014.
Nov 03, 2014 at 10:26 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, auto sector will continue getting strong astrological support and advises buying Mahindra and Mahindra, Tata Motors, SML Isuzu, Maruti Suzuki India, Escorts, Force Motors and Eicher Motors on dips.
Nov 03, 2014 at 08:30 | Source: CNBC-TV18
Tata Motors | M&M | NMDC | Karnataka Bank | JSW Energy | Cairn India | Ranbaxy Labs | JSW Steel | IOC | Bank of India | Dabur | GVK Power | Tata Comm | United Spirits | Panacea Biotec | Suzlon Energy | Divis Labs | Godrej Consumer | PFC | TVS Motor Company | CESC and GMR Infra are stocks, which are in the news today.
Messages on Astrazeneca »

babuji555

Platinum Member

651 Followers

L&T Finance  

buy , ashapura –grab it ..target 250 in 6 to 8 months , 450 in 2 years time , surya roshni , astrazeneca, WELCAST, GRPL , BAJAJ STEEL , GMM PFAUD… Look at them from a point of view of a” potential mis-pricing opportunities…” in these stocks::::…..goodluck and godbless.

8.57 PM Jul 7th

livelovelau
gh

Platinum Member

440 Followers

Maha ShreeUmaid  

Right now promoters of Dic india ,fulford ,astrazeneca and ahlcon parent have got approved postal ballot resolution wherein thinly traded company UMS techno is starting rbb and Reil electronic is in the process to secure postal ballot approval.

1.31 PM Jul 7th

AstraZeneca  

Shooting up! Good news in the cards. Buy, last chance before revised delisting price announced. - My target for AstraZeneca is Rs 1600 for the short term with a stoploss of Rs 1100

1.11 PM Jul 2nd

babuji555

Platinum Member

651 Followers

ITC  

buy , ashapura –grab it ..target 250 in 6 to 8 months , 450 in 2 years time , surya roshni , astrazeneca, WELCAST, GRPL , BAJAJ STEEL , GMM PFAUD… Look at them from a point of view of a” potential mis-pricing opportunities…” in these stocks::::…..goodluck and godbless.

9.02 PM Jun 29th

babuji555

Platinum Member

651 Followers

ONGC  

buy , ashapura –grab it ..target 250 in 6 to 8 months , 450 in 2 years time , surya roshni , astrazeneca, WELCAST, GRPL , BAJAJ STEEL , GMM PFAUD… Look at them from a point of view of a” potential mis-pricing opportunities…” in these stocks::::…..goodluck and godbless.

8.41 PM Jun 29th

livelovelau
gh

Platinum Member

440 Followers

Essar Oil  

there will be a schedule soon wherein last date for voting and result date will be announced. in the history of d listing there has been only 2 cases where shareholders have rejected d listing at postal ballot or in other words one can say promoters failed to manage postal ballot of Astrazeneca

11.34 AM Jun 27th

Ricoh India  

Traders cautious on delisting after Ricoh India bets turn sour Distinctly less agression in AstraZeneca and Essar Oil cases after earlier bet on Ricoh went sour; fear of stock price fall Sneha Padiyath & Samie Modak | Mumbai June 25, 2014 Last Updated at 22:49 IST on Business Standard

7.30 PM Jun 26th

john_H

Silver Member

28 Followers

AstraZeneca  

Hold on. Astrazeneca will not be abke to fool the small investors and get away with delisting by manipulating the book building process. Sebi has its watchful eyes on it. .

6.28 PM Jun 25th

Stock Tracker

Platinum Member

1045 Followers

AstraZeneca  

Will AstraZeneca Pharmaceuticals AB Sweden be able to delist its subsidiary Astrazeneca Pharma India from BSE and NSE?

5.47 PM Jun 25th

livelovelau
gh

Platinum Member

440 Followers

Fulford  

TODAY ...postal ballot result of 2 mnc`s ASTRAZENECA and FULFORD !

11.02 AM Jun 20th

News across the web »
Nov 20, 2014 at 22:00 | Source: NDTV Profit
Nov 07, 2014 at 12:42 | Source: Calcutta Telegraph News
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.